Figures & data
Figure 1 Venn diagram of prognostic gene markers for the three gene expression microarray data cohorts (TCGA-LAML, GSE12417 HG-U133A, and HG-U133 plus 2.0 cohorts).
Abbreviations: HR, hazard ratio; TCGA-LAML, The Cancer Genome Atlas AML project.
![Figure 1 Venn diagram of prognostic gene markers for the three gene expression microarray data cohorts (TCGA-LAML, GSE12417 HG-U133A, and HG-U133 plus 2.0 cohorts).](/cms/asset/e01b9904-1b12-485c-b89e-a99450b06858/dott_a_12195706_f0001_c.jpg)
Figure 2 The prognostic value of the 11 genes for AML patients in the GSE12417 HG-U133A cohort.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
![Figure 2 The prognostic value of the 11 genes for AML patients in the GSE12417 HG-U133A cohort.](/cms/asset/35896403-667b-43c0-9f24-a146bdb00217/dott_a_12195706_f0002_c.jpg)
Figure 3 The prognostic value of the 11 genes for AML patients in the GSE12417 HG-U133 plus 2.0 cohort.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
![Figure 3 The prognostic value of the 11 genes for AML patients in the GSE12417 HG-U133 plus 2.0 cohort.](/cms/asset/76bd4ab6-03ed-43b0-be93-decdbc102030/dott_a_12195706_f0003_c.jpg)
Figure 4 The prognostic value of the 11 genes for AML patients in the TCGA-LAML cohort.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5; TCGA-LAML, The Cancer Genome Atlas AML project.
![Figure 4 The prognostic value of the 11 genes for AML patients in the TCGA-LAML cohort.](/cms/asset/a7002b4e-9846-4dea-8f02-014d2ed540d3/dott_a_12195706_f0004_c.jpg)
Figure 5 Prognostic gene signature of the 11 genes in AML patients of the GSE12417 HG-U133A cohort.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
![Figure 5 Prognostic gene signature of the 11 genes in AML patients of the GSE12417 HG-U133A cohort.](/cms/asset/bb6c2521-8270-4e22-84cb-cafce46a95ad/dott_a_12195706_f0005_c.jpg)
Table 1 Prognostic value of the 11 genes in AML patients of the three cohorts
Figure 6 Prognostic gene signature of the 11 genes in AML patients of GSE12417 HG-U133 plus 2.0 cohort.
Abbreviations: AUC, area under the ROC curve; AML, acute myeloid leukemia; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
![Figure 6 Prognostic gene signature of the 11 genes in AML patients of GSE12417 HG-U133 plus 2.0 cohort.](/cms/asset/4b26c00a-80bc-4c12-a511-0316031d5090/dott_a_12195706_f0006_c.jpg)
Figure 7 Prognostic gene signature of the 11 genes in AML patients of the TCGA-LAML cohort.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic; TCGA-LAML, The Cancer Genome Atlas AML project.
![Figure 7 Prognostic gene signature of the 11 genes in AML patients of the TCGA-LAML cohort.](/cms/asset/89d38ea4-d1db-443e-bf1d-b0ce4569e014/dott_a_12195706_f0007_c.jpg)
Figure 8 The expression level distribution of the 11 genes in the low- and high-risk groups.
Abbreviation: TCGA-LAML, The Cancer Genome Atlas AML project.
![Figure 8 The expression level distribution of the 11 genes in the low- and high-risk groups.](/cms/asset/4b0f52cd-f263-4b74-93a4-8a1e360c926c/dott_a_12195706_f0008_c.jpg)
![Figure 8 The expression level distribution of the 11 genes in the low- and high-risk groups.](/cms/asset/6a20468a-1d15-4c50-9935-a667c0f4915a/dott_a_12195706_f0008a_c.jpg)